Adiponectin and cardiovascular remodeling in end-stage renal disease and co-morbid diabetes mellitus

被引:15
作者
Karakitsos, Dimitrios
De Groot, Eric
Patrianakos, Alexandros P.
Parthenakis, Frangiscos
Boletis, John
Karabinis, Andreas
Kyriazis, John
Vardas, Panos
Daphnis, Eugene
机构
[1] Heraklion Univ Hosp, Dept Nephrol, GR-71110 Iraklion, Crete, Greece
[2] Heraklion Univ Hosp, Dept Cardiol, GR-71110 Iraklion, Crete, Greece
[3] Gen State Hosp, Intens Care Unit, Athens, Greece
[4] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[5] Laiko Univ Hosp, Renal Transplantat Unit, Athens, Greece
[6] Gen Hosp Chios, Dialysis Unit, Chios, Greece
关键词
end-stage renal disease; diabetes mellitus; adiponectin; cardiovascular remodeling;
D O I
10.1159/000094403
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives and Methods: Altered plasma high-sensitivity C-reactive protein (hs-CRP) and adiponectin (ADP) may contribute to increased vascular inflammation and accelerated atherosclerosis in patients with end-stage renal disease (ESRD) and co-morbid diabetes. Common carotid artery intima-media thickness (CCA-IMT) and atherosclerotic plaque occurrence, left-ventricular mass index (LVMI), and pulse wave velocity of the proximal aorta (PWVr) were determined by ultrasound imaging in 120 ESRD (55 diabetic) patients, and 83 age-, sex-, and blood pressure-matched controls. Also, plasma levels of ADP and hs-CRP were determined and their relationships with the above cardiovascular alterations were analyzed. Results: LVMI, PWVr, CCA-IMT and atherosclerotic plaque occurrence were all increased in ESRD patients compared to controls (all p < 0.001). LVMl (p < 0.05), PWVr (p < 0.001), CCA-IMT (p < 0.001) and atherosclerotic plaque occurrence (p < 0.001) were increased in diabetic compared to nondiabetic ESRD patients. Hs-CRP levels were increased and ADP levels were decreased in diabetic compared to nondiabetic ESRD patients (both p < 0.001). ADP levels correlated inversely with hs-CRP (r=-0.473, p < 0.0001) in ESRD patients. Hs-CRP was positively correlated with LVMI (r = 0.365, p < 0.0001), PWVr (r = 0.42, p < 0.0001) and CCA-IMT (r = 0.18, p, = 0.047) while ADP inversely correlated with PWVr (r = -0.263, p = 0.0035) and CCA-IMT (r = -0.207, p = 0.022) in ESRD patients. Conclusion: The present results indicate diabetic disease-specific alterations in the biochemical parameters of hs-CRP and ADP in ESRD patients. The above biochemical parameters were intimately linked to the cardiovascular measurements of LVMI, PWVr and CCA-IMT in patients with ESRD and co-morbid diabetes mellitus. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:340 / 347
页数:8
相关论文
共 50 条
  • [21] The challenge of cardiovascular risk factors in end-stage renal disease
    Covic, A
    Gusbeth-Tatomir, P
    Goldsmith, DJA
    JOURNAL OF NEPHROLOGY, 2003, 16 (04) : 476 - 486
  • [22] Adiponectin receptor and adiponectin signaling in human tissue among patients with end-stage renal disease
    Cantarin, Maria P. Martinez
    Keith, Scott W.
    Waldman, Scott A.
    Falkner, Bonita
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (12) : 2268 - 2277
  • [23] Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease
    Sharma, Sumeet
    Farrington, Ken
    Kozarski, Robert
    Christopoulos, Christos
    Niespialowska-Steuden, Maria
    Moffat, Daniel
    Gorog, Diana A.
    EUROPEAN HEART JOURNAL, 2013, 34 (05) : 354 - +
  • [24] Familiality of Cardiovascular Mortality in End-Stage Renal Disease Patients
    Naiman, Natalie
    Cheung, Alfred K.
    Goldfarb-Rumyantzev, Alexander S.
    AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (03) : 237 - 243
  • [25] Guest editorial: Cardiovascular care in end-stage renal disease
    McCullough, PA
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2004, 11 (03) : 245 - 245
  • [26] High Fibrinogen Levels with Diabetes Mellitus are Associated with All-Cause and Cardiovascular Mortality in Patients with End-Stage Renal Disease and Acute Coronary Syndrome
    Xie, Enmin
    Wu, Yaxin
    Ye, Zixiang
    Gao, Yanxiang
    Zheng, Jingang
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 7409 - 7422
  • [27] Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease
    Marchlewska, A
    Stenvinkel, P
    Lindholm, B
    Danielsson, A
    Pecoits, R
    Lönnqvist, F
    Schalling, M
    Heimbürger, O
    Nordfors, L
    KIDNEY INTERNATIONAL, 2004, 66 (01) : 46 - 50
  • [28] Common co-morbid conditions associated with type 2 diabetes mellitus
    Shaha, Kartick Chanda
    Rahman, Md Shamsur
    Shahnaz, Tasmin
    Habibunnahar
    BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2020, 19 (02): : 237 - 239
  • [29] Changing trends in end-stage renal disease patients with diabetes
    Lu Yimin
    Stamm, Christina
    Nobre, Dina
    Pruijm, Menno
    Teta, Daniel
    Cherpillod, Anne
    Halabi, Georges
    Phan, Olivier
    Fumeaux, Zina
    Bullani, Roberto
    Gauthier, Thierry
    Mathieu, Claudine
    Burnier, Michel
    Zanchi, Anne
    SWISS MEDICAL WEEKLY, 2017, 147
  • [30] Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007-2011
    Assogba, Frank G. A.
    Couchoud, Cecile
    Hannedouche, Thierry
    Villar, Emmanuel
    Frimat, Luc
    Fagot-Campagna, Anne
    Jacquelinet, Christian
    Stengel, Benedicte
    DIABETOLOGIA, 2014, 57 (04) : 718 - 728